Clinical Trials Details

A031704 PDIGREE (Renal)

PD-Inhibitor (Nivolumab) and Ipilimumab followed by Nivolumab vs. VEGF TKI Cabozantinib with Nivolumab: A Phase III trial in Metastatic untreated RENAL Cell CANCER

Clinical Trial Categories

  • Cancers and Other Neoplasms